Abbott (ABT): plans to spin off its $8.5bn Nutrition business as Q3 adjusted profit per share rises 9% to $1.42
Abbott, the maker of medical devices, diagnostic tests, generic medicines and infant formula, said on 21 October 2026 that it intends to separate its…